Lung Cancer Trials Ask AI to find trials
UnknownNot applicableNCT01842555
Official study title

Photodynamic Therapy (PDT) Oncology Registry

Study summary

The data elements for the PDT Registry project include virtually all the elements in the standard hospital-based cancer registry record, although in some cases at a finer level of detail. All data points should be found in the participant's medical record. The principal difference between the PDT Registry data set and that collected by the registries is the inclusion of more information specific to PDT.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedRegistry

The study team can explain what participation involves.

Who it may be forLung Cancer · Esophageal

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 24, 2018 · Source: ClinicalTrials.gov

Is enrollment open?Unknown

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Main Line Health

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Main Line Health
Interventions being studied
Other: Registry
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • 18 years of age or older, male or female, diagnosed with cancer and is undergoing or has undergone Photodynamic Therapy (PDT).
  • Patients must have undergone PDT with Photofrin® at a participating institution.
  • Patients scheduled to undergo PDT with Photofrin®
  • Cancer patients receiving some or all primary care (e.g.,cancer-directed surgery, systemic therapy, radiation therapy, palliative care)in the participating institution.
  • Cancer patients with a history of any type of cancer who have been no evidence of disease(for five years but without a history of distant metastases or evidence of relapse if they meet the previous criteria).
Reasons someone may not be able to joinExclusion criteria
  • Cancer patients who present to the participating institution with a diagnosis of a simultaneous second primary.
  • Cancer patients receiving all primary cancer care (e.g., cancer-directed surgery, chemotherapy, targeted therapy, radiation therapy, palliative care) outside of participating institution.
  • Patients treated with photosensitizers other than Photofrin®

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Main Line Health, Lankenau Medical CenterWynnewood, Pennsylvania

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 24, 2018. Always confirm current availability with the study team.

View original record ↗